Another mechanism of SETDB1 involvement in cancer is the suppression of tumor-intrinsic immunogenicity and evasion of the immune response through inhibition of genome regions enriched with transposable elements that would trigger the host’s immune responses if activated [58]. This evidence concerns the gene SETDB1 and neoplasm.